Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China

BACKGROUND: There is a paucity of large‐scale studies evaluating the clinical benefit of the Gaviscon Double Action (DA) alginate‐antacid formulation for treating gastroesophageal reflux disease (GERD) symptoms. AIM: Randomised double‐blind placebo‐controlled parallel‐group study to evaluate efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, J., Yang, C., Zhao, H., Zheng, P., Wilkinson, J., Ng, B., Yuan, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Randomised Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042071/
https://www.ncbi.nlm.nih.gov/pubmed/26228097
http://dx.doi.org/10.1111/apt.13334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042071/
https://www.ncbi.nlm.nih.gov/pubmed/26228097
http://dx.doi.org/10.1111/apt.13334

Ejemplares similares